<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04144699</url>
  </required_header>
  <id_info>
    <org_study_id>HDV-CDD-190046</org_study_id>
    <nct_id>NCT04144699</nct_id>
  </id_info>
  <brief_title>Clinical Validation of Omron WheezeScan</brief_title>
  <official_title>Clinical Validation of Omron WheezeScan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Omron Healthcare Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Le Bonheur Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Omron Healthcare Co., Ltd.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The WheezeScan sensitivity and specificity are set to statistically prove equal to or higher
      values than the predicate PulmoTrack device model 2020.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2019</start_date>
  <completion_date type="Anticipated">March 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the sensitivity and specificity of the Omron WheezeScan device</measure>
    <time_frame>Novemver 1, 2019 ~ January 22, 2020</time_frame>
    <description>The WheezeScan device will be compared to the gold standard, auscultation, which will be performed by a physician or a qualified healthcare professional with a minimum of 3 years' experience. All breath sounds will be recorded for comparison in case of discrepancy.</description>
  </primary_outcome>
  <enrollment type="Anticipated">384</enrollment>
  <condition>Asthma in Children</condition>
  <condition>Bronchitis</condition>
  <condition>Bronchiolitis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Wheezing 3~11months : 32(min29) Wheezing 12~23months : 32(min29) Wheezing 24~35months :
        32(min29) Wheezing 36~107months : 96(min87) No wheezing 3~11months : 32(min29) No wheezing
        12~23months : 32(min29) No wheezing 24~35months : 32(min29) No wheezing 36~107months :
        96(min91)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Mild to moderate diagnosed or suspected asthma, bronchitis, or bronchiolitis patients who
        meet all of the following criteria are considered as eligible.

          1. Does the subject have mild to moderate diagnosed or suspected asthma, bronchitis, or
             bronchiolitis?

          2. Is the subject between the ages of 3 months to 8 years old?

          3. Is the parent or legal guardian available, and capable and willing to give a consent
             on the child's behalf.

        Exclusion Criteria:

        The subjects will be excluded from the study, if they have any of the following criteria.

          1. Does the subject have skin rashes or wounds on the chest?

          2. Does the subject have known allergies or irritant contact dermatitis or having
             hypersensitive skin?

          3. Does the subject have a defibrillator and/or pacemaker (which could interfere with the
             sounds to be detected)?

          4. Does the subject have an allergy to disinfecting alcohol?

          5. Does the subject have wheezes caused by not asthma, such as reflux esophagitis,
             pneumonia, vocal cord dysfunction, Tracheomatosis?

          6. Does the subject have a heavy runny nose?

          7. Is it difficult to hear auscultation due to the subject fussing, crying or vocalizing
             at data collection?

          8. Is the subject having difficulty breathing or having severe symptoms?

          9. Was the subject enrolled more than once for the same resulted breath sounds?

               -  Note: The subject maybe enrolled once per arm (once wheezing, once non-wheezing).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Naoto Ohgami, 37</last_name>
    <phone>+81-75-925-2304</phone>
    <email>naoto.ogami@omron.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tammy Kennedy</last_name>
    <email>tammy.kennedy@omron.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachelle Ramsey</last_name>
    </contact>
    <contact_backup>
      <last_name>Sophie Kollin</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 28, 2019</study_first_submitted>
  <study_first_submitted_qc>October 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2019</study_first_posted>
  <last_update_submitted>November 27, 2019</last_update_submitted>
  <last_update_submitted_qc>November 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>wheeze</keyword>
  <keyword>rhonchus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
    <mesh_term>Bronchitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plan to share the data</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

